Recombinant tissue-type plasminogen activator treatment in an extremely low birth weight infant

Tomonori Kurimoto1, Yoshikazu Shimoji1, Atsuya Shimabukuro1

  • 1Okinawa Prefectural Nanbu Medical Center and Children's Medical Center Okinawa Japan.

Insights

Tissue plasminogen activator effectively treats thrombosis in premature infants. This therapy shows promise for neonatal care within hours of birth.

Area of Science:

  • Neonatal Medicine
  • Pharmacology

Background:

  • Clinical thrombosis is a significant concern in premature infants.
  • Early intervention is crucial for managing neonatal thromboembolic events.